Mark Liddament in Parkville, Victoria works at CSL (Director, Head of Antibody Discovery and Protein Engineering) and was educated at University of Cambridge.
Share this profile
CSL
Jun 2019
-
Present
Director, Head of Antibody Discovery and Protein Engineering
Teva Pharmaceuticals
Aug 2014
-
Jun 2019
Associate Director, Lead Antibody Discovery
OBodies Ltd.
Sep 2010
-
Jul 2014
Principal Scientist
University of Cambridge
1999
-
2003
PhD. Biochemistry, Molecular Biology
Queen Mary, University of London
1996
-
1999
BSc (Hons). Biochemistry and Microbiology
RELATED SEARCHES
AT CSL